Author: Jha, Nishant; Prashar, Deepak; Rashid, Mamoon; Shafiq, Mohammad; Khan, Razaullah; Pruncu, Catalin I.; Tabrez Siddiqui, Shams; Saravana Kumar, M.
Title: Deep Learning Approach for Discovery of In Silico Drugs for Combating COVID-19 Cord-id: oc3ogvye Document date: 2021_7_20
ID: oc3ogvye
Snippet: Early diagnosis of pandemic diseases such as COVID-19 can prove beneficial in dealing with difficult situations and helping radiologists and other experts manage staffing more effectively. The application of deep learning techniques for genetics, microscopy, and drug discovery has created a global impact. It can enhance and speed up the process of medical research and development of vaccines, which is required for pandemics such as COVID-19. However, current drugs such as remdesivir and clinical
Document: Early diagnosis of pandemic diseases such as COVID-19 can prove beneficial in dealing with difficult situations and helping radiologists and other experts manage staffing more effectively. The application of deep learning techniques for genetics, microscopy, and drug discovery has created a global impact. It can enhance and speed up the process of medical research and development of vaccines, which is required for pandemics such as COVID-19. However, current drugs such as remdesivir and clinical trials of other chemical compounds have not shown many impressive results. Therefore, it can take more time to provide effective treatment or drugs. In this paper, a deep learning approach based on logistic regression, SVM, Random Forest, and QSAR modeling is suggested. QSAR modeling is done to find the drug targets with protein interaction along with the calculation of binding affinities. Then deep learning models were used for training the molecular descriptor dataset for the robust discovery of drugs and feature extraction for combating COVID-19. Results have shown more significant binding affinities (greater than −18) for many molecules that can be used to block the multiplication of SARS-CoV-2, responsible for COVID-19.
Search related documents:
Co phrase search for related documents- absence presence and active inactive: 1
- absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63
- absence presence and logistic regression model: 1, 2, 3, 4, 5, 6, 7
- absence presence and loss function: 1, 2
- absence presence and low molecular weight: 1, 2, 3
- absence presence and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- absence presence and machine learning model: 1, 2, 3, 4
- accuracy validation and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- accuracy validation and logistic regression model: 1, 2, 3, 4, 5
- accuracy validation and loss function: 1, 2, 3
- accuracy validation and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- accuracy validation and machine learning model: 1, 2, 3, 4, 5, 6, 7, 8
- acetylcholinesterase inhibitor and low molecular weight: 1
- activation function and log loss function: 1
- activation function and loss function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- activation function and machine learning: 1, 2, 3, 4, 5, 6
- activation function and machine learning model: 1
Co phrase search for related documents, hyperlinks ordered by date